EUVIMEDObjevte EUVIMED
Crossref

Feasibility and Safety of Medium‐Term Remote‐Only Monitoring in a Large Cohort of Biotronik Pacemaker Patients

Markus Sane iD, Toni Jäntti, Annukka Marjamaa, Elina Pennanen, Charlotte Aura, Eeva Torvinen, Leena Karjalainen, Jarkko Karvonen, Pekka Raatikainen iD

Pacing and Clinical Electrophysiology · 2026-08-06

DOI: 10.1111/pace.70389 ↗

At a glance

Journal article in Pacing and Clinical Electrophysiology, published online on 2026-08-06. Written by Markus Sane and 8 co-authors. Institution: Helsinki University Hospital Heart and Lung Center, Helsinki, Finland. 24 references. Funded by: Aarne Koskelo Foundation, Paavo Nurmi Foundation, Päivikki and Sakari Sohlberg Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Remote monitoring (RM) enables convenient follow‐up of patients with cardiac implantable electronic devices. In remote‐only monitoring (RM‐only), in‐person visits are only scheduled if needed based on RM findings. This study evaluated the feasibility and safety of medium‐term RM‐only of pacemaker (PM) patients.

Methods

All patients with Biotronik PM were included in the analysis. Data on the number and causes of additional in‐office device interrogations, actions due to the transmissions, hospitalizations and performance of RM were collected from a large cohort of PM patients followed by RM‐only.

Results

In total, 606 patients (302 females) with a mean age of 78 ± 12 years were included in the analysis. During the mean follow‐up of 2.8 years, 445 additional in‐office device interrogations were made in 287 patients (0.3 interrogations/year), and in 110 (25%) of these cases, changes to device programming were made. In a subgroup analysis of 100 patients with at least one year of prior appointment‐based device monitoring, the need for in‐office visits was 6.9 times higher per follow‐up year than in RM (IRR = 6.9, 95% CI 4.9–9.9; p < 0.001). The hospitalization rate in the entire cohort during RM was 0.3 / year with no difference in the rate of hospitalizations between the two monitoring methods (IRR 1, 95% CI 0.8–1.4, p = 0.8). The success of daily transmissions was 91.7%.

Conclusion

Our real‐world data indicate that RM‐only may be a viable option for long‐term follow‐up of PM patients. Portions of this manuscript contain text overlap with our previously published work because they describe the same methodology and standard clinical procedures. All overlapping material has been appropriately cited, and no previously published data, results, or conclusions have been duplicated without attribution.

Subjects

Author keywords

alert transmissionhospitalizationinterrogationsremote monitoringsafety

Authors and institutions

  • Helsinki University Hospital Heart and Lung Center, Helsinki, Finland.
  • Helsinki University, Helsinki, Finland.

ORCID profiles: Markus Sane, Pekka Raatikainen

Funding

  • Aarne Koskelo Foundation
  • Paavo Nurmi Foundation
  • Päivikki and Sakari Sohlberg Foundation
  • Finnish Foundation for Cardiovascular Research
  • Aarne Koskelon Säätiö
  • Paavo Nurmen Säätiö
  • Päivikki ja Sakari Sohlbergin Säätiö
  • Sydäntutkimussäätiö

Cite

APA

Sane, M., Jäntti, T., Marjamaa, A., Pennanen, E., Aura, C., Torvinen, E., Karjalainen, L., Karvonen, J., & Raatikainen, P. (2026). Feasibility and Safety of Medium‐Term Remote‐Only Monitoring in a Large Cohort of Biotronik Pacemaker Patients. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70389

Vancouver

Sane M, Jäntti T, Marjamaa A, Pennanen E, Aura C, Torvinen E, et al. Feasibility and Safety of Medium‐Term Remote‐Only Monitoring in a Large Cohort of Biotronik Pacemaker Patients. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70389

BibTeX
@article{Sane2026,
  author = {Sane, Markus and Jäntti, Toni and Marjamaa, Annukka and Pennanen, Elina and Aura, Charlotte and Torvinen, Eeva and Karjalainen, Leena and Karvonen, Jarkko and Raatikainen, Pekka},
  title = {Feasibility and Safety of Medium‐Term Remote‐Only Monitoring in a Large Cohort of Biotronik Pacemaker Patients},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  doi = {10.1111/pace.70389}
}
Start for free →